Navigation Links
New Analyses of long-term LIALDA (mesalamine) data presented at ACG
Date:10/15/2007

Philadelphia, PA October 15, 2007 Post-hoc and other analyses of secondary endpoints of a long-term safety and tolerability study of Shire plc's (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) ulcerative colitis (UC) drug LIALDA (mesalamine) provide further data on LIALDA in patients with mild to moderate ulcerative colitis. These analyses of LIALDAs 303 trial, a long-term, Phase III, open-label 12-14 month extension study, are being presented this week at The American College of Gastroenterology (ACG) meeting in Philadelphia.

The primary endpoint of study 303 was safety and tolerability and findings that LIALDA is generally well tolerated in mild to moderate UC patients were presented at the British Society of Gastroenterology (BSG) meeting in Glasgow, Scotland in March 2007.

"Earlier studies showed that LIALDA is well-tolerated and effective at inducing remission in patients with active, mild to moderate UC. Post-hoc analysis of secondary endpoints provided evidence that LIALDA maintained remission in a variety of UC patients, said Gary R. Lichtenstein, M.D., director of the Center for Inflammatory Bowel Diseases at the Hospital of the University of Pennsylvania.

A summary of key scientific presentations of post-hoc analyses of secondary endpoints of study 303 follows.


Once or Twice Daily Lialda for Mild vs. Moderate Ulcerative Colitis
Poster Presentation: Tuesday, October 16, 2007, Exhibit Hall B, #950

A post-hoc analysis of secondary endpoints from the long-term 303 study was performed to review the efficacy of LIALDA for maintaining remission in patients with mild versus moderate ulcerative colitis. In the 303 study, patients were randomized to receive LIALDA 2.4g/day (given once daily [QD]) or 2.4g/day (1.2g given twice daily [BID]). Study 303 defined patient remission using stringent clinical and endoscopic measures: modified UC Disease Activity Index (UC-DAI) score of ≤1 with score
'/>"/>

Contact: Ashleigh Duchene
aduchene@golinharris.com
312-729-4428
Shire plc
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Using Body Mass Index Skews Analyses on Obesity Rates
2. A New Study Analyses Benefits Of Statin Drug
3. UAE Analyses HIV Policies to Plan National Strategy
4. Pancreatitis: Minimially Invasive Procedure Offers Long-Term Pain Relief
5. Long-Term Survival can be Predicted by a Simple Lung Test
6. Small lumps in breast if not treated may cause long-term harm
7. Lung Therapy Found To Have Long-Term Side Effects
8. Long-Term Benefits Of Statins Questioned
9. Long-term use of calcium supplements to prevent colon cancer
10. Survivors of childhood cancer may have long-term health problems
11. Long-term Care Should Be A Planned Affair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2015)... Ohio (PRWEB) May 02, 2015 On ... Liverpool City Hospital (ELCH) gathered to celebrate improvements in ... River Valley Health Partners (RVHP), had zero acquired ventilator ... urinary catheter associated infections. ELCH was also recently named ... The management team at ELCH credited the teamwork of ...
(Date:5/1/2015)... Frisco, Texas (PRWEB) May 02, 2015 ... Frisco, Texas, is proud to announce the addition of ... Jen Widerstrom is a life long athlete, growing up ... fitness passion after college by becoming a personal trainer ... since been the face of several TV shows highlighting ...
(Date:5/1/2015)... Va. (PRWEB) May 01, 2015 The ... nation’s leading nonprofit authority on the use of health ... as a key contributing resource to the United States ... use of electronically readable cards in Medicare. The report, ... and Providers ” was released to the public on ...
(Date:5/1/2015)... Linda, CA (PRWEB) May 01, 2015 ... our genetic makeup and the interplay of genes with ... up with developments can be daunting. , LabRoots, the ... and clinical diagnostics professionals, will soon host its annual ... , At BioConference Live Genetics and Genomics 2015 ...
(Date:5/1/2015)... May 01, 2015 The frozen yogurt ... the Hickory Crawdads (NC) and the Myrtle Beach Pellicans ... in-stadium concession locations and offer fans discounts at local ... the Hickory Community,” said Luke Shook, co-owner of the ... opportunity and we look forward to enjoying the games ...
Breaking Medicine News(10 mins):Health News:East Liverpool City Hospital Celebrates Patient Care Improvements 2Health News:IDLife LLC Announces New Partnership with Fitness Celebrity, Jen Widerstrom 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 3Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 2Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 3Health News:sweetFrog Announces Minor League Baseball Partnerships 2
... cancer treatment, chemobrain a range of symptoms including ... subtle cognitive changes following chemotherapy seriously diminishes women,s ... they have to adopt a range of coping strategies ... Breast cancer survivors tell their story in a ...
... , SAN DIEGO, Sept. 17 ... that the company,s first laboratory developed test, the SensiGene(TM) Cystic ... is available exclusively through the Sequenom Center for Molecular Medicine, ... laboratory and a wholly-owned subsidiary of Sequenom, Inc. , ...
... Office of Minority Health Urges "Know Your Risk and Help ... 17 Speaking at the Venous Disease Coalition (VDC) Annual Meeting ... the Department of Health and Human Services followed up on last ... African American population which is at significantly increased risk of Deep ...
... , DALLAS, Sept. 17 The Texas ... released its annual report on the prevalence, cost and quality ... includes information for key local markets across the state including ... Also included are state and national benchmarks that can help ...
... set by CDC need to be lowered, experts say , ... levels well below those considered safe are still at risk ... , Currently, the maximum safe blood level of lead is ... the U.S. Centers for Disease Control and Prevention in 1991. ...
... ... communications company. , ... Knoxville, TN (PRWeb) Sept. 17, 2009 -- Alan Weinstein was recently named chairman of ... innovative ways to leverage PerfectServe,s physician-contact network serving physician practices and hospitals nationwide. , ...
Cached Medicine News:Health News:Chemobrain -- the flip side of surviving cancer 2Health News:SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test 2Health News:SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test 3Health News:SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test 4Health News:SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test 5Health News:SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test 6Health News:African Americans at Significantly Higher Risk of DVT or Blood Clots 2Health News:African Americans at Significantly Higher Risk of DVT or Blood Clots 3Health News:African Americans at Significantly Higher Risk of DVT or Blood Clots 4Health News:TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 2Health News:TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 3Health News:TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 4Health News:Even Small Amounts of Lead Harmful to Kids 2Health News:Even Small Amounts of Lead Harmful to Kids 3Health News:Alan Weinstein Named Chairman of PerfectServe Advisory Board 2
(Date:4/30/2015)... NASHVILLE, Tenn. , April 30, 2015  Cumberland ... it will release first quarter 2015 financial results after ... conference call and live Internet webcast will be held ... Time to discuss the results. To participate ... or 253-237-1032 (for international callers).  A rebroadcast of the ...
(Date:4/30/2015)... 2015  Nektar Therapeutics (Nasdaq: NKTR ) today ... March 31, 2015. Cash and investments ... million as compared to $262.8 million at December 31, ... March 31, 2015 includes a $100.0 million milestone payment ... commercial sale of Movantik™(naloxegol) in the U.S. ...
(Date:4/30/2015)... plc (NYSE: PRGO ; TASE) today announced that Perrigo Chairman, ... the 2015 Deutsche Bank 40 th Annual Healthcare Conference at ... in Boston , MA.  The ... C. Papa will present at the Bank of America Merrill ... 2015 at the Encore at Wynn Las Vegas Hotel in ...
Breaking Medicine Technology:Cumberland Pharmaceuticals To Announce First Quarter 2015 Financial Results 2Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 2Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 3Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 4Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 5Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 6Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 7Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 8Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 9Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 10Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 11Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 12Perrigo Company To Present At Upcoming Healthcare Conferences 2Perrigo Company To Present At Upcoming Healthcare Conferences 3
... Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) today announced that ... New Drugs ("OND") in Maryland and presented its arguments supporting ... Drug Application ("NDA") 22-481 support the conclusion that pixantrone is ... consideration of our appeal.  While we understand disputes of this ...
... SQNM ), today announced the awards of non-qualified ... common stock for six new employees under the company,s New ... Of these shares, 14,450 have an exercise price ... Sequenom,s common stock on February 28, and 60,000 have a ...
Cached Medicine Technology:FDA's Office of New Drugs Meets With Cell Therapeutics on its Appeal on Pixantrone 2FDA's Office of New Drugs Meets With Cell Therapeutics on its Appeal on Pixantrone 3Sequenom Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 2Sequenom Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: